Show Summary Details
Page of

Chronic lower limb ischaemia 

Chronic lower limb ischaemia
Chapter:
Chronic lower limb ischaemia
Author(s):

Alan G. Dawson

and Julie Brittenden

DOI:
10.1093/med/9780199658220.003.0026
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 September 2019

Intermittent claudication affects up to 5% of the population aged 55–74 years of age, and may be associated with significant disability and impaired quality of life (QOL). Patients have an increased cardiovascular mortality and require appropriate cardiovascular risk factor management. Revascularization may be indicated for patients with intermittent claudication with significantly impaired QOL or who failed to benefit from supervised exercise therapy. Critical limb ischaemia (CLI) affects 1.2% of patients aged 60 years For patients with CLI, revascularization with angioplasty or surgery is recommended. Treatment choice will depend on patient co-morbidities and preference, anatomical location of the disease and the presence of a suitable vein conduit. Endovascular procedures are being used increasingly, yet surgery remains the preferred treatment option for extensive aorto-iliac lesions, lesions of the common femoral artery and long lesions of the superficial femoral artery. The evidence for the various treatment options, outcome, and complications are discussed.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.